Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Copeland

Showing results (301-310 of 449) with videos related to

Pageof 45
Sort By:
Gynecologic Oncology|May 1, 1984
Carcinoma of the cervical stumpB E Miller, L J Copeland, A D Hamberger, et al.
Gynecologic Oncology|April 13, 2013
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group studyLisa M Landrum, James Java, Cara A Mathews, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?D E Cohn, J C Pavelka, W L Frankel, et al.
The Laryngoscope|July 29, 2004
Cochlear implantation for children with GJB2-related deafnessRobert D Cullen, Craig A Buchman, Carolyn J Brown, et al.
The Annals of Thoracic Surgery|April 1, 1986
The cardiac donor: a six-year experienceR W Emery, R C Cork, M M Levinson, et al.
Cancer|June 1, 1985
Endodermal sinus tumor of the vagina and cervixL J Copeland, N Sneige, N G Ordonez, et al.
Cancer|March 1, 1985
Prognosis of surgically determined complete responders in advanced ovarian cancerD M Gershenson, L J Copeland, J T Wharton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2014
Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 studyRitu Salani, David M O'Malley, Larry J Copeland, et al.
Journal of Public Health (Oxford, England)|March 28, 2015
Reducing the impact of physical inactivity: evidence to support the case for targeting people with chronic mental and physical conditionsEmma S Everson-Hock, Mark A Green, Elizabeth C Goyder, et al.
Gynecologic Oncology|December 17, 2003
Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?Jaina Lindauer, Jeffrey M Fowler, Tom P Manolitsas, et al.
Pageof 45

Showing results (301-310 of 449) with videos related to

Sort By:
Pageof 45
Gynecologic Oncology|May 1, 1984
Carcinoma of the cervical stumpB E Miller, L J Copeland, A D Hamberger, et al.
Gynecologic Oncology|April 13, 2013
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group studyLisa M Landrum, James Java, Cara A Mathews, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?D E Cohn, J C Pavelka, W L Frankel, et al.
The Laryngoscope|July 29, 2004
Cochlear implantation for children with GJB2-related deafnessRobert D Cullen, Craig A Buchman, Carolyn J Brown, et al.
The Annals of Thoracic Surgery|April 1, 1986
The cardiac donor: a six-year experienceR W Emery, R C Cork, M M Levinson, et al.
Cancer|June 1, 1985
Endodermal sinus tumor of the vagina and cervixL J Copeland, N Sneige, N G Ordonez, et al.
Cancer|March 1, 1985
Prognosis of surgically determined complete responders in advanced ovarian cancerD M Gershenson, L J Copeland, J T Wharton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2014
Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 studyRitu Salani, David M O'Malley, Larry J Copeland, et al.
Journal of Public Health (Oxford, England)|March 28, 2015
Reducing the impact of physical inactivity: evidence to support the case for targeting people with chronic mental and physical conditionsEmma S Everson-Hock, Mark A Green, Elizabeth C Goyder, et al.
Gynecologic Oncology|December 17, 2003
Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?Jaina Lindauer, Jeffrey M Fowler, Tom P Manolitsas, et al.
Pageof 45